Page last updated: 2024-09-04

bila 2157 bs and atazanavir

bila 2157 bs has been researched along with atazanavir in 1 studies

Compound Research Comparison

Studies
(bila 2157 bs)
Trials
(bila 2157 bs)
Recent Studies (post-2010)
(bila 2157 bs)
Studies
(atazanavir)
Trials
(atazanavir)
Recent Studies (post-2010) (atazanavir)
50075137

Protein Interaction Comparison

ProteinTaxonomybila 2157 bs (IC50)atazanavir (IC50)
Solute carrier organic anion transporter family member 2B1 Homo sapiens (human)5.2
UDP-glucuronosyltransferase 1A1 Homo sapiens (human)0.375
UDP-glucuronosyltransferase 1A1 Rattus norvegicus (Norway rat)4.2
Reverse transcriptase/RNaseH Human immunodeficiency virus 10.026
Protease Human immunodeficiency virus 10.004
Solute carrier organic anion transporter family member 1B3Homo sapiens (human)0.4
Solute carrier organic anion transporter family member 1B1Homo sapiens (human)1.4
Protease Human immunodeficiency virus 10.0017

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Abbenante, G; Fairlie, DP; Leung, D1

Reviews

1 review(s) available for bila 2157 bs and atazanavir

ArticleYear
Protease inhibitors: current status and future prospects.
    Journal of medicinal chemistry, 2000, Feb-10, Volume: 43, Issue:3

    Topics: Animals; Aspartic Acid Endopeptidases; Cysteine Endopeptidases; Cysteine Proteinase Inhibitors; Humans; Metalloendopeptidases; Models, Molecular; Protease Inhibitors; Serine Endopeptidases; Serine Proteinase Inhibitors

2000